血小板凝集設備市場規模、佔有率和成長分析：按產品、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年血小板凝集設備市場規模為5.3319億美元，從2023年的5.6119億美元增加到2031年的8.8942億美元，複合年成長率預計將成長5.25%。

由於多種因素，全球市場正在大幅擴張。世界範圍內目標疾病數量的增加和老年人口的增加是這一上升趨勢的主要驅動力。此外，血小板凝集測量技術的進步對於血小板功能和相關疾病的研究至關重要，也正在推動市場成長。此外，產學界合作的增加和臨床研究的激增正在推動創新並進一步擴大市場。儘管取得了積極進展，但醫療保健程序限制、美國醫療保健系統不利的改革以及熟練專業人員的短缺等挑戰仍然是市場成長潛力的主要障礙。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價格分析
• 價值鏈分析
• 市場生態系統
• 監管環境
• 創新矩陣
• 主要投資分析
• 關鍵成功因素
• 市場魅力指數
• 競爭程度

血小板凝集設備市場：按產品

• 市場概況
• 系統
• 試劑
• 耗材/配件

血小板凝集裝置市場：依應用分類

• 市場概況
• 臨床應用
  • 心血管
  • 整形外科
  • 其他
• 研究用途

血小板凝集設備市場：依最終用戶分類

• 市場概況
• 獨立醫院
• 診斷實驗室
• 研究/學術機構
• 其他

血小板凝集設備市場規模：依地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Aggredyne, Inc.（United States）
• Helena Laboratories Corporation（United States）
• Haemonetics Corporation（United States）
• Bio/Data Corporation（United States）
• Sysmex Corporation（Japan）
• TEM Innovations GmbH（Germany）
• Helena Biosciences Europe（United Kingdom）
• Chrono-log Corporation（United States）
• Helena Biosciences（United States）
• Sentinel CH. SpA（Italy）
• WerfenLife SA（Spain）
• Stago（France）
• Abbott Laboratories（United States）
• Drucker Diagnostics（United States）
• Rayto Life and Analytical Sciences Co., Ltd.（China）
• Technoclone GmbH（Austria）
• Diagnostica Stago, Inc.（United States）
• Chronolog Corporation（United States）

Platelet Aggregation Devices Market size was valued at USD 533.19 million in 2022 and is poised to grow from USD 561.19 million in 2023 to USD 889.42 million by 2031, growing at a CAGR of 5.25% in the forecast period (2024-2031).

The global market is undergoing significant expansion driven by multiple factors. Rising incidences of target diseases and the expanding elderly population worldwide are major contributors to this upward trend. Technological advancements in platelet aggregometry, crucial for studying platelet function and associated disorders, are also propelling market growth. Moreover, increasing collaborations between industry and academia, coupled with a surge in clinical studies, are fostering innovation and further expanding the market. Despite these favorable developments, challenges such as procedural constraints within healthcare, adverse reforms in the U.S. healthcare system, and a shortage of skilled professionals pose significant obstacles to the market's potential growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Platelet Aggregation Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Platelet Aggregation Devices Market Segmental Analysis

Platelet Aggregation Devices Market is segmented on the basis of product, application, end user, and region. Based on product, the market is segmented into Systems, Reagents, and Consumables & Accessories. Based on application, the market is segmented into Clinical Applications (Cardiovascular Applications, Orthopedic Applications, Other Clinical Applications), Research Applications. Based on end user, the market is segmented into Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Drivers of the Platelet Aggregation Devices Market

The rising global demand for platelet aggregation devices presents significant growth prospects for stakeholders in this market. This demand surge is driven by the growing prevalence of chronic and bleeding disorders worldwide. As these medical conditions become more prevalent, there is an escalating requirement for advanced diagnostic and monitoring tools. Platelet aggregation devices are crucial in evaluating platelet function, thus playing a pivotal role in diagnosing and managing a variety of coagulation-related disorders. This trend underscores the increasing importance of these devices in healthcare settings globally.

Restraints in the Platelet Aggregation Devices Market

The growth of the global market for platelet aggregation devices is hindered by significant challenges, primarily stemming from the high costs involved in acquiring these devices and a concurrent shortage of skilled personnel. The substantial expenses associated with purchasing platelet aggregation devices present a formidable hurdle for healthcare organizations and facilities, constraining their capacity to make investments in these sophisticated diagnostic tools. Furthermore, the scarcity of trained personnel exacerbates the situation, affecting the efficient utilization and maintenance of these devices.

Market Trends of the Platelet Aggregation Devices Market

The increasing prevalence of hemostasis disorders worldwide is fueling a rapid rise in the need for platelet aggregation devices. This heightened demand stems from the pivotal role of platelet aggregation testing in diagnosing hemostasis and bleeding disorders. Hemostasis disorders encompass various conditions that disrupt the body's blood clotting process, potentially leading to complications in coagulation. Platelet aggregation devices are essential instruments for evaluating platelet function and identifying abnormalities in blood clotting mechanisms, thereby aiding in the diagnosis of these disorders. With the incidence of hemostasis disorders expected to continue rising, the global market for platelet aggregation devices is projected to expand significantly. This trend is anticipated to drive sustained growth in the market throughout the forecast period, establishing it as a major catalyst for market expansion.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Global Platelet Aggregation Devices Market by Product

• Market Overview
• Systems
• Reagents
• Consumables & Accessories

Global Platelet Aggregation Devices Market by Application

• Market Overview
• Clinical Applications
  • Cardiovascular Applications
  • Orthopedic Applications
  • Other Clinical Applications
• Research Applications

Global Platelet Aggregation Devices Market by End User

• Market Overview
• Standalone hospitals
• Diagnostic laboratories
• Research & academic institutes
• Other end users

Global Platelet Aggregation Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aggredyne, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio/Data Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TEM Innovations GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Biosciences Europe (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chrono-log Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Biosciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentinel CH. SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WerfenLife S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stago (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayto Life and Analytical Sciences Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Technoclone GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diagnostica Stago, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chronolog Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments